Harrison Seth Loring

CIK 00014049556 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001404955

Recent Transactions

50 trades

Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−13,000→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−26,000→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Common Stock
2025-12-09−9,398→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−15,000→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Common Stock
2025-12-09−148,063→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Common Stock
2025-12-09−136,301→ 0 total
Award
Stoke Therapeutics, Inc.$STOK
Director Stock Option (Right to Buy)
2025-06-03+29,747→ 29,747 total
Award
Akero Therapeutics, Inc.
Common Stock
2025-06-03+9,398→ 145,699 total
Award
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2024-06-08+26,000→ 26,000 total
Award
Stoke Therapeutics, Inc.$STOK
Director Stock Option (Right to Buy)
2024-06-05+7,639→ 7,639 total
Award
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2023-06-23+15,000→ 15,000 total
Award
Stoke Therapeutics, Inc.$STOK
Director Stock Option (Right to Buy)
2023-06-13+19,441→ 19,441 total
Sale
Akero Therapeutics, Inc.
Common Stock
2022-11-30$46.44/sh−6,322→ 141,080 total
Sale
Akero Therapeutics, Inc.
Common Stock
2022-11-30$47.60/sh−4,779→ 136,301 total
Sale
Akero Therapeutics, Inc.
Common Stock
2022-11-30$47.60/sh−5,179→ 148,063 total
Sale
Akero Therapeutics, Inc.
Common Stock
2022-11-30$46.44/sh−6,851→ 153,242 total
Sale
Akero Therapeutics, Inc.
Common Stock
2022-10-28$41.12/sh−869→ 160,093 total
Sale
Akero Therapeutics, Inc.
Common Stock
2022-10-28$40.28/sh−20,338→ 148,202 total
Sale
Akero Therapeutics, Inc.
Common Stock
2022-10-28$41.12/sh−800→ 147,402 total
Sale
Akero Therapeutics, Inc.
Common Stock
2022-10-28$40.28/sh−22,096→ 160,962 total
Sale
Akero Therapeutics, Inc.
Common Stock
2022-10-27$42.03/sh−21,830→ 172,233 total
Sale
Akero Therapeutics, Inc.
Common Stock
2022-10-27$43.23/sh−4,013→ 183,058 total
Sale
Akero Therapeutics, Inc.
Common Stock
2022-10-27$43.23/sh−3,693→ 168,540 total
Sale
Akero Therapeutics, Inc.
Common Stock
2022-10-27$41.12/sh−40,903→ 194,063 total
Sale
Akero Therapeutics, Inc.
Common Stock
2022-10-27$41.12/sh−44,440→ 210,790 total
Sale
Akero Therapeutics, Inc.
Common Stock
2022-10-27$42.03/sh−23,719→ 187,071 total
Sale
Akero Therapeutics, Inc.
Common Stock
2022-10-26$44.90/sh−18,486→ 234,966 total
Sale
Akero Therapeutics, Inc.
Common Stock
2022-10-26$43.97/sh−11,539→ 253,452 total
Sale
Akero Therapeutics, Inc.
Common Stock
2022-10-26$43.08/sh−38,961→ 287,852 total
Sale
Akero Therapeutics, Inc.
Common Stock
2022-10-26$43.97/sh−12,537→ 275,315 total
Sale
Akero Therapeutics, Inc.
Common Stock
2022-10-26$43.08/sh−35,860→ 264,991 total
Sale
Akero Therapeutics, Inc.
Common Stock
2022-10-26$44.90/sh−20,085→ 255,230 total
Sale
Akero Therapeutics, Inc.
Common Stock
2022-10-25$44.92/sh−4,906→ 326,813 total
Sale
Akero Therapeutics, Inc.
Common Stock
2022-10-25$44.92/sh−4,515→ 300,851 total
Award
Stoke Therapeutics, Inc.$STOK
Director Stock Option (Right to Buy)
2022-06-07+21,000→ 21,000 total
Award
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-02+15,000→ 15,000 total
Award
Stoke Therapeutics, Inc.$STOK
Director Stock Option (Right to Buy)
2021-06-08+11,650→ 11,650 total
Award
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2021-06-01+13,000→ 13,000 total
Purchase
Stoke Therapeutics, Inc.$STOK
Common Stock
2020-11-24$39.00/sh+375,000→ 17,161,713 total
Purchase
Akero Therapeutics, Inc.
Common Stock
2020-07-10$36.00/sh+415,000→ 5,830,203 total
Award
Stoke Therapeutics, Inc.$STOK
Director Stock Option (Right to Buy)
2020-06-03+14,777→ 14,777 total
Award
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2020-06-01+13,000→ 13,000 total
Award
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2019-11-08+26,000→ 26,000 total
Award
Stoke Therapeutics, Inc.$STOK
Director Stock Option (Right to Buy)
2019-09-10+29,555→ 29,555 total
Conversion
Akero Therapeutics, Inc.
Series B Preferred Stock
2019-06-24−880,568→ 0 total
Purchase
Akero Therapeutics, Inc.
Common Stock
2019-06-24$16.00/sh+900,000→ 5,415,203 total
Conversion
Akero Therapeutics, Inc.
Common Stock
2019-06-24+286,439→ 4,515,203 total
Conversion
Akero Therapeutics, Inc.
Series A Preferred Stock
2019-06-24−13,000,000→ 0 total
Conversion
Akero Therapeutics, Inc.
Common Stock
2019-06-24+4,228,764→ 4,228,764 total
Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2019-06-21+4,980,168→ 4,980,168 total

Companies

Recent Filings

Address

APPLE TREE PARTNERS ONE BROADWAY, 14TH FLOOR

CAMBRIDGE, MA, 02142

View on SEC.gov